Lessons Learned Accelerate Vaccine Development
April 14, 2016 - BioPharm Intl.
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing.
By Cynthia A. Challener
…
Updated Ion Exchange Chromatography (IEX) Handbook
March 30, 2016 - Cytiva
The ion exchange chromatography handbook has been updated to include the expanding range of Capto chromatography media for lab- and large-scale protein purifica
…
A Risk-Based Genetic Characterization Strategy for Recombinant CH
March 30, 2016 - BioPharm Intl.
The authors describe the ways in which manufacturers can mitigate the risks related to the integrity of recombinant transgenes expressed in CHO cells.
…
Adherent Cell Culture in Biopharmaceutical Applications: The Cell
March 16, 2016 - BioPharm Intl.
The necessity to detach cells from a culture substrate during cell harvesting remains one of the most challenging steps in a cell-culture process.
…
Developing Cleaning-in-Place Protocols
March 16, 2016 - Cytiva
Cleaning conditions for chromatography media can be screened in a
Antibody Production in Microbial Hosts
February 18, 2016 - BioPharm Intl.
The authors review the status of expression of antibodies in microbial hosts and present the recent advances in the production of aglycosylated antibodi
…
Innovative Therapies Require Modern Manufacturing Systems
February 18, 2016 - BioPharm Intl.
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.
By Jill Wechsler
A Q&A With Jeff Carter on Trends in Single-Use Technologies
February 18, 2016 - Process Development Forum
Process Development Forum speaks with Jeff Carter, Strategic Projects Leader at Cytiva, and first Vice Chair on the executive board of the Bio-
…
Framing Biopharma Success in 2016
February 4, 2016 - BioPharm Intl.
Corporate restructurings, regulatory initiatives, and biosimilars will shape biopharma development in 2016.
By Rita C. Peters
…
KUBio modular biopharm facility built in Germany, assembled in Ch
January 22, 2016 - Cytiva
Cytiva is supplying a full biopharmaceutical processing so